Multimodal Treatment With Gene Therapy

Posted on: October 21, 2023 *Updated on: May 27, 2024

---

Gene therapy is a fascinating and rapidly advancing field of medicine that has the potential to revolutionize the treatment of a wide range of diseases, including cancer. Mesothelioma, a rare form of cancer primarily caused by exposure to asbestos, has been notoriously difficult to treat. Traditional treatments like chemotherapy, radiation, and surgery often offer limited effectiveness. In this context, gene therapy offers a ray of hope for more effective and targeted therapies.

Types of Gene Therapy Approaches for Cancer Treatment

1. Gene Silencing: One approach aims to silence or “turn off” the genes that promote cancer growth. This is often achieved through techniques like RNA interference (RNAi).
2. Gene Addition: Alternatively, “good” genes that promote cell death or prevent cell division in cancerous cells may be inserted.
3. Gene Editing: Technologies like CRISPR/Cas9 allow for the precise editing of genes. This could involve removing mutations that lead to cancer or inserting sequences that counteract the cancerous activity.
4. Oncolytic Virus Therapy: In this method, a virus is genetically modified to infect and kill cancer cells while sparing normal cells. The virus may be further modified to carry therapeutic genes into the cancer cells.
5. Immunomodulation: Gene therapy can also be used to enhance the body’s immune response to cancer. This could involve modifying T-cells to target cancer cells more effectively.

Multimodal Treatment

The term “multimodal” refers to combining multiple forms of treatment for a more comprehensive approach. In the case of mesothelioma, this could mean combining gene therapy with traditional treatments like chemotherapy or newer treatments like oncolytic virus therapy. The idea is to exploit the strengths of each type of therapy while minimizing their weaknesses.

1. Gene Therapy + Chemotherapy: Gene therapy may make cancer cells more susceptible to chemotherapy or allow for lower doses to be used, reducing side effects.
2. Gene Therapy + Oncolytic Virus Therapy: Combining these two could have a synergistic effect. The oncolytic virus could act as a vector for delivering therapeutic genes, while the gene therapy could make the cancer cells more susceptible to viral infection.
3. Gene Therapy + Radiation: Radiation could be used to shrink tumors to a more manageable size, allowing for more effective gene delivery.

Clinical Trials and Challenges

Several clinical trials are underway to test the efficacy of gene therapy for mesothelioma and other forms of cancer. However, the approach is not without challenges:

• Safety: Any alteration to a person’s genetic code carries risks, such as unwanted mutations or immune reactions.
• Delivery: Getting the modified genes into the cancer cells efficiently is a significant hurdle.
• Regulation: Governmental oversight and ethical considerations can slow down the speed at which new treatments become available.
• Cost: Gene therapies are often expensive, making them less accessible for many patients.

In summary, gene therapy offers an exciting but challenging frontier in the treatment of mesothelioma and other cancers. A multimodal approach, combining gene therapy with other treatments, could offer the best chance for a cure or long-term management of the disease. However, more research and clinical trials are needed to fully understand the risks and benefits.